Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The Wegovy pill has been approved for long-term weight loss
Drug interactions: not characterised
But cagrilintide won decisively on tolerability: GI adverse events 54.0% vs 73.8%, and discontinuation for adverse events 2.6% vs 3.6% (cagrilintide was actually below the 3.5% placebo rate)
I picked this up mainly for gut support and it has made a real difference in how I feel after meals
Best-studied use case Gastrointestinal healing plus tendon and ligament research, where a concentrated, site-specific effect is the priority
US$ 24.72
US$ 23.84
US$ 21.15
